Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ebony N Gary

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Molecular Therapy Oncolytics|January 24, 2022
DNA immunotherapy targeting BARF1 induces potent anti-tumor responses against Epstein-Barr-virus-associated carcinomasXizhou Zhu, Alfredo Perales-Puchalt, Krzysztof Wojtak, et al.
Molecular Therapy Oncolytics|March 14, 2023
Multivalent <i>in vivo</i> delivery of DNA-encoded bispecific T cell engagers effectively controls heterogeneous GBM tumors and mitigates immune escapeDaniel H Park, Kevin Liaw, Pratik Bhojnagarwala, et al.
Frontiers in Immunology|December 12, 2025
Synthetic DNA co-immunization with vaccine-aligned common consensus nucleoprotein and hemagglutinin protects mice against lethal influenza infection with a single immunizationEbony N Gary, Abigail R Trachtman, Dan Wang, et al.
Cell Reports. Medicine|July 15, 2022
Mucosal chemokine adjuvant enhances synDNA vaccine-mediated responses to SARS-CoV-2 and provides heterologous protection in vivoEbony N Gary, Nicholas J Tursi, Bryce Warner, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 15, 2026
Multivalent DNA vaccines induce potent cellular responses and prolong BCG-mediated control of Mycobacterium tuberculosisElizabeth M Parzych, Mamadou A Bah, Nicholas J Tursi, et al.
Journal of Clinical Microbiology|August 29, 2020
SARS-CoV-2 Assays To Detect Functional Antibody Responses That Block ACE2 Recognition in Vaccinated Animals and Infected PatientsSusanne N Walker, Neethu Chokkalingam, Emma L Reuschel, et al.
Trends in Biotechnology|June 19, 2026
Engineering single-dose plasmid DNA for sustained in vivo delivery of designer incretinsEbony N Gary, Yangcheng Gao, Casey E Hojecki, et al.
Frontiers in Immunology|June 23, 2025
Intramuscular DNA vaccine provides protection in non-human primate and mouse models of SARS-CoV-2Subeena Sood, Ebony N Gary, Majed Matar, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 28, 2026
Nanoparticle Immunoadjuvant Complexes Augment Germinal Center Responses to VaccinationNicholas J Tursi, Colby J Agostino, Jinwei Huang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2022
Improved Durability to SARS-CoV-2 Vaccine Immunity following Coimmunization with Molecular Adjuvant Adenosine Deaminase-1Gina M Cusimano, Ebony N Gary, Matthew R Bell, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Molecular Therapy Oncolytics|January 24, 2022
DNA immunotherapy targeting BARF1 induces potent anti-tumor responses against Epstein-Barr-virus-associated carcinomasXizhou Zhu, Alfredo Perales-Puchalt, Krzysztof Wojtak, et al.
Molecular Therapy Oncolytics|March 14, 2023
Multivalent <i>in vivo</i> delivery of DNA-encoded bispecific T cell engagers effectively controls heterogeneous GBM tumors and mitigates immune escapeDaniel H Park, Kevin Liaw, Pratik Bhojnagarwala, et al.
Frontiers in Immunology|December 12, 2025
Synthetic DNA co-immunization with vaccine-aligned common consensus nucleoprotein and hemagglutinin protects mice against lethal influenza infection with a single immunizationEbony N Gary, Abigail R Trachtman, Dan Wang, et al.
Cell Reports. Medicine|July 15, 2022
Mucosal chemokine adjuvant enhances synDNA vaccine-mediated responses to SARS-CoV-2 and provides heterologous protection in vivoEbony N Gary, Nicholas J Tursi, Bryce Warner, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 15, 2026
Multivalent DNA vaccines induce potent cellular responses and prolong BCG-mediated control of Mycobacterium tuberculosisElizabeth M Parzych, Mamadou A Bah, Nicholas J Tursi, et al.
Journal of Clinical Microbiology|August 29, 2020
SARS-CoV-2 Assays To Detect Functional Antibody Responses That Block ACE2 Recognition in Vaccinated Animals and Infected PatientsSusanne N Walker, Neethu Chokkalingam, Emma L Reuschel, et al.
Trends in Biotechnology|June 19, 2026
Engineering single-dose plasmid DNA for sustained in vivo delivery of designer incretinsEbony N Gary, Yangcheng Gao, Casey E Hojecki, et al.
Frontiers in Immunology|June 23, 2025
Intramuscular DNA vaccine provides protection in non-human primate and mouse models of SARS-CoV-2Subeena Sood, Ebony N Gary, Majed Matar, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 28, 2026
Nanoparticle Immunoadjuvant Complexes Augment Germinal Center Responses to VaccinationNicholas J Tursi, Colby J Agostino, Jinwei Huang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2022
Improved Durability to SARS-CoV-2 Vaccine Immunity following Coimmunization with Molecular Adjuvant Adenosine Deaminase-1Gina M Cusimano, Ebony N Gary, Matthew R Bell, et al.
Pageof 4